895
Participants
Start Date
May 31, 2006
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
7.5% hypertonic saline/6% Dextran-70 (HSD)
250 cc dose given as a one-time intravenous (IV) bolus in the pre-hospital setting.
7.5% hypertonic saline (HS)
250 cc dose given as a one-time IV bolus in the pre-hospital setting.
0.9% normal saline
250 cc dose given as a one-time IV bolus in the pre-hospital setting.
The Pittsburgh Resuscitation Network, University of Pittsburgh, Pittsburgh
Alabama Resuscitaion Center, University of Alabama, Birmingham
Iowa Resuscitation Network, University of Iowa Carver College of Medicine, Iowa City
Milwaukee Resuscitation Network, Medical College of Wisconsin, Milwaukee
Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center, Dallas
UCSD-San Diego Resuscitation Research Center, San Diego
Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University, Portland
Seattle-King County Center For Resuscitation Research, University of Washington, Seattle
University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute, Ottawa
Toronto Regional Resuscitation Research Out-of-Hospital Network, University of Toronto, Toronto
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
The Institute of Circulatory and Respiratory Health (ICRH)
UNKNOWN
Defence Research and Development Canada
INDUSTRY
University of Washington
OTHER